NCT02593097View on ClinicalTrials.gov

Metformin for the Prevention of Episodic Migraine (MPEM)

PHASE3CompletedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions

Migraine

Interventions

DRUG

Metformin

Metformin 500mg twice daily

DRUG

Matching Placebo

Matching Placebo twice daily

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER